| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
77,230,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. AT-007 is a central nervous system penetrant ARI that Co. is developing for the treatment of metabolic diseases, including Galactosemia, a pediatric metabolic disease that affects how the body processes a simple sugar called galactose. AT-001 is an ARI with systemic exposure and peripheral nerve permeability that Co. is developing for the treatment of diabetic cardiomyopathy. AT-003 is an ARI designed to cross through the back of the eye when dosed orally for the treatment of diabetic retinopathy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
30,000 |
30,000 |
3,691,409 |
| Total Buy Value |
$0 |
$65,367 |
$65,367 |
$3,658,451 |
| Total People Bought |
0 |
1 |
1 |
3 |
| Total Buy Transactions |
0 |
1 |
1 |
5 |
| Total Shares Sold |
506,975 |
933,491 |
1,224,775 |
1,252,098 |
| Total Sell Value |
$2,732,596 |
$3,725,309 |
$4,466,825 |
$4,492,358 |
| Total People Sold |
4 |
6 |
6 |
7 |
| Total Sell Transactions |
4 |
10 |
14 |
18 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Perfetti Riccardo |
Chief Medical Officer |
• – – |
2020-10-28 |
4 |
OE |
$1.44 |
$670 |
D/D |
465 |
465 |
|
- |
|
| Perfetti Riccardo |
Chief Medical Officer |
• – – |
2020-10-27 |
4 |
AS |
$21.20 |
$9,858 |
D/D |
(465) |
0 |
|
- |
|
| Perfetti Riccardo |
Chief Medical Officer |
• – – |
2020-10-27 |
4 |
OE |
$1.44 |
$670 |
D/D |
465 |
465 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-10-02 |
4 |
AS |
$20.07 |
$119,938 |
D/D |
(5,976) |
17,148 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-10-01 |
4 |
AS |
$20.03 |
$482,175 |
D/D |
(24,024) |
23,124 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-10-01 |
4 |
OE |
$4.70 |
$141,000 |
D/D |
30,000 |
47,148 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-08-24 |
4 |
S |
$24.18 |
$156,227 |
D/D |
(6,461) |
17,148 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-08-24 |
4 |
AS |
$23.42 |
$317,083 |
D/D |
(13,539) |
23,609 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-08-21 |
4 |
OE |
$4.70 |
$94,000 |
D/D |
20,000 |
37,148 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-22 |
4 |
AS |
$25.45 |
$384,876 |
D/D |
(15,000) |
554,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-22 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-21 |
4 |
AS |
$26.69 |
$405,834 |
D/D |
(15,000) |
554,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-21 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-20 |
4 |
AS |
$27.19 |
$410,079 |
D/D |
(15,000) |
554,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-20 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-09 |
4 |
AS |
$30.90 |
$466,507 |
D/D |
(15,000) |
554,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-09 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-08 |
4 |
AS |
$32.21 |
$484,775 |
D/D |
(15,000) |
554,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-08 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-07 |
4 |
AS |
$31.63 |
$482,513 |
D/D |
(15,000) |
554,285 |
|
- |
|
| Shendelman Shoshana |
President and CEO |
• • • |
2020-07-07 |
4 |
OE |
$1.44 |
$21,600 |
D/D |
15,000 |
569,285 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-06-25 |
4 |
S |
$36.12 |
$30,450 |
D/D |
(817) |
17,148 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-06-24 |
4 |
S |
$39.20 |
$310,393 |
D/D |
(7,783) |
17,965 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-06-23 |
4 |
S |
$43.32 |
$507,712 |
D/D |
(11,400) |
25,748 |
|
- |
|
| Funtleyder Leslie D. |
Director |
– • – |
2020-06-22 |
4 |
OE |
$4.70 |
$94,000 |
D/D |
20,000 |
37,148 |
|
- |
|
243 Records found
|
|
Page 8 of 10 |
|
|
